Concepedia

C. Tyler Kirkland

CT

Statistics

Publications

4

Citations

354

H-Index

4

Active since

2010

Affiliations

National Cancer Institute(Current)

C. Tyler Kirkland is an author at National Cancer Institute specializing in pharmacology, medicine, and cancer genetics.

Publications per year

2010–2024

4

Publications

4

Sorafenib Is an Inhibitor of UGT1A1 but Is Metabolized by UGT1A9: Implications of Genetic Variants on Pharmacokinetics and Hyperbilirubinemia

Cody J. Peer, Tristan M. Sissung, AeRang Kim et al. · Clinical Cancer Research · 2012 · 130 citations · Full text

Medicine, Oncology, Pharmacology +15

RNA Interference With Zilebesiran for Mild to Moderate Hypertension

George L. Bakris, Manish Saxena, Anil Gupta et al. · JAMA · 2024 · 116 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +17

Comparative outcomes between robotic and abdominal radical hysterectomy for IB1 cervical cancer: Results from a single high volume institution

David W. Doo, C. Tyler Kirkland, Lauren Griswold et al. · Gynecologic Oncology · 2019 · 78 citations · Full text

Medicine, Gynecology, Surgery +15

Estrogen Receptor α and Aromatase Polymorphisms Affect Risk, Prognosis, and Therapeutic Outcome in Men with Castration-Resistant Prostate Cancer Treated with Docetaxel-Based Therapy

Tristan M. Sissung, Romano Danesi, C. Tyler Kirkland et al. · The Journal of Clinical Endocrinology & Metabolism · 2010 · 30 citations · Full text

Medicine, Oncology, Pharmacology +17

1–4 of 4